Search
Now showing items 1-1 of 1
The Dose-Dependent Antiangiogenic Potential of Apixaban: An Experimental Outlook
(2022)
Aim: Direct oral anticoagulants (DOACs) are good alternatives to conventional
medical regimens for the treatment and prevention of thromboembolism. Apixaban
is one of the more popular variations of these newly developed ...